首页 > 最新文献

Integrative Medicine Research最新文献

英文 中文
Efficacy of personalized acupuncture combined with accelerated deep transcranial magnetic stimulation in mild cognitive impairment: A randomized controlled trial 个体化针刺联合加速深经颅磁刺激治疗轻度认知障碍的疗效:一项随机对照试验
IF 3 4区 医学 Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2026-09-01 Epub Date: 2026-01-05 DOI: 10.1016/j.imr.2026.101289
Jing Xia , Xinhe Wu , Zitao Wang , Lei Zhang , Ping Xu , Peipei Zhao , Peilong Liu , Yanan Shao , Xipeng Zhang , Yiran Lu , Xiaojie Qin , Xinjian Song

Background

This study evaluated the efficacy of combining personalized acupuncture with accelerated deep transcranial magnetic stimulation (adTMS) for mild cognitive impairment (MCI).

Methods

In this randomized, double-blind, controlled trial, 120 MCI patients were assigned to a Combined group (personalized acupuncture + active adTMS), a Single Stimulation group (active adTMS + sham acupuncture), or a Placebo group (sham TMS + sham acupuncture). The primary outcome was the change in Montreal Cognitive Assessment (MoCA) score at 12 weeks. Secondary outcomes included P300 latency, magnetic resonance spectroscopy (MRS) NAA/Cr ratio, serum brain-derived neurotrophic factor (BDNF), C-reactive protein (CRP), interleukin-6 (IL-6), and the Modified Barthel Index (MBI).

Results

The Combined group showed a significantly greater improvement in MoCA scores (3.2 ± 1.3 points) compared to the Single Stimulation (1.9 ± 1.2 points; mean difference 1.3, 95 % CI 0.4 to 2.2) and Placebo groups (1.1 ± 1.0 points; mean difference 2.1, 95 % CI 1.2 to 3.0). The Combined group also demonstrated greater reductions in P300 latency and increases in NAA/Cr ratio and serum BDNF levels than the other groups.

Conclusion

The combination of personalized acupuncture and adTMS significantly improves cognitive function in MCI patients, supported by positive changes in electrophysiological and metabolic markers. This integrative approach represents a promising non-pharmacological strategy for MCI.
Trial registration: International Traditional Medicine Clinical Trials Registry (ITMCTR2025000652).
本研究评价个体化针刺联合加速深经颅磁刺激(adTMS)治疗轻度认知障碍(MCI)的疗效。方法随机、双盲、对照试验将120例MCI患者分为联合组(个性化针灸+主动adTMS)、单刺激组(主动adTMS +假针灸)和安慰剂组(假TMS +假针灸)。主要结果是12周时蒙特利尔认知评估(MoCA)评分的变化。次要指标包括P300潜伏期、磁共振波谱(MRS) NAA/Cr比值、血清脑源性神经营养因子(BDNF)、c反应蛋白(CRP)、白细胞介素-6 (IL-6)和改良Barthel指数(MBI)。结果联合组MoCA评分(3.2±1.3分)较单纯刺激组(1.9±1.2分,平均差异1.3分,95% CI 0.4 ~ 2.2)和安慰剂组(1.1±1.0分,平均差异2.1分,95% CI 1.2 ~ 3.0)有显著性改善。与其他组相比,联合治疗组也表现出P300潜伏期的更大降低,NAA/Cr比率和血清BDNF水平的增加。结论个体化针刺与adTMS联合治疗可显著改善MCI患者的认知功能,并伴有电生理和代谢指标的积极变化。这种综合方法代表了一种有希望的MCI非药物治疗策略。试验注册:国际传统医学临床试验注册中心(ITMCTR2025000652)。
{"title":"Efficacy of personalized acupuncture combined with accelerated deep transcranial magnetic stimulation in mild cognitive impairment: A randomized controlled trial","authors":"Jing Xia ,&nbsp;Xinhe Wu ,&nbsp;Zitao Wang ,&nbsp;Lei Zhang ,&nbsp;Ping Xu ,&nbsp;Peipei Zhao ,&nbsp;Peilong Liu ,&nbsp;Yanan Shao ,&nbsp;Xipeng Zhang ,&nbsp;Yiran Lu ,&nbsp;Xiaojie Qin ,&nbsp;Xinjian Song","doi":"10.1016/j.imr.2026.101289","DOIUrl":"10.1016/j.imr.2026.101289","url":null,"abstract":"<div><h3>Background</h3><div>This study evaluated the efficacy of combining personalized acupuncture with accelerated deep transcranial magnetic stimulation (adTMS) for mild cognitive impairment (MCI).</div></div><div><h3>Methods</h3><div>In this randomized, double-blind, controlled trial, 120 MCI patients were assigned to a Combined group (personalized acupuncture + active adTMS), a Single Stimulation group (active adTMS + sham acupuncture), or a Placebo group (sham TMS + sham acupuncture). The primary outcome was the change in Montreal Cognitive Assessment (MoCA) score at 12 weeks. Secondary outcomes included P300 latency, magnetic resonance spectroscopy (MRS) NAA/Cr ratio, serum brain-derived neurotrophic factor (BDNF), C-reactive protein (CRP), interleukin-6 (IL-6), and the Modified Barthel Index (MBI).</div></div><div><h3>Results</h3><div>The Combined group showed a significantly greater improvement in MoCA scores (3.2 ± 1.3 points) compared to the Single Stimulation (1.9 ± 1.2 points; mean difference 1.3, 95 % CI 0.4 to 2.2) and Placebo groups (1.1 ± 1.0 points; mean difference 2.1, 95 % CI 1.2 to 3.0). The Combined group also demonstrated greater reductions in P300 latency and increases in NAA/Cr ratio and serum BDNF levels than the other groups.</div></div><div><h3>Conclusion</h3><div>The combination of personalized acupuncture and adTMS significantly improves cognitive function in MCI patients, supported by positive changes in electrophysiological and metabolic markers. This integrative approach represents a promising non-pharmacological strategy for MCI.</div><div>Trial registration: International Traditional Medicine Clinical Trials Registry (ITMCTR2025000652).</div></div>","PeriodicalId":13644,"journal":{"name":"Integrative Medicine Research","volume":"15 3","pages":"Article 101289"},"PeriodicalIF":3.0,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146024919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative effectiveness of Chinese herbal medicine versus liraglutide for weight loss in adults with obesity: A 12-month real-world target trial emulation study 中草药与利拉鲁肽对成人肥胖患者减肥的比较效果:一项为期12个月的真实世界目标试验模拟研究
IF 3 4区 医学 Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2026-09-01 Epub Date: 2026-01-06 DOI: 10.1016/j.imr.2026.101291
Yu-Ning Liao , Tsung-Hsien Yang , Yi-Chin Lu , Liang-Wei Tseng , Ching-Wei Yang , Yu-Tung Huang , Hsing-Yu Chen

Background

Chinese herbal medicine (CHM) is commonly used for weight control in Taiwan. This study aimed to compare the effectiveness and mechanisms of a fixed combination of CHM with liraglutide using a target trial emulation real-world study.

Methods

From January 1, 2013, to December 31, 2018, subjects from the multi-institutional Chang Gung Research Database (CGRD) with a BMI ≥ 25 kg/m² received a fixed combination of Ma-Xing-Gan-Shi-Tang and Coptis chinensis Franch, namely Ma-Xing-Gan-Shi-Tang and Coptis chinensis Franch LOwering Weight formula (MCLOW), were compared with those using liraglutide for weight control for a 12-month follow-up course with overlap weighting for baseline inequality.

Results

Among 376 subjects, 135 (35.9%) used MCLOW, who lost more weight from baseline (-6.07 [95% CI:6.90 to -5.24] vs. -1.66 [95% CI:2.22 to -1.1] kg; p-value < 0.001), and had a higher proportion achieved weight reductions of ≥ 5% and ≥ 10% (68.15% vs. 23.65%, p < 0.001 and 32.59% vs. 7.05%, p-value < 0.001, respectively). The results were consistent with overlap and inverse probability of treatment weighting models. By using network pharmacology, use of MCLOW was associated with lipid metabolism and immune-related pathways, while liraglutide was linked to insulin-secretion pathways.

Conclusion

The CHM formula MCLOW appears to have promising effects on weight loss, with mechanisms differing from but complementary to those of Western medicines.
在台湾,中草药(CHM)常被用来控制体重。本研究旨在通过目标试验模拟现实世界研究,比较中药与利拉鲁肽固定联合的有效性和机制。方法2013年1月1日至2018年12月31日,来自多机构长庚研究数据库(CGRD)的BMI≥25 kg/m²的受试者,接受了固定的马行甘湿汤和黄连的组合,即马行甘湿汤和黄连的降体重公式(MCLOW),并与使用利拉鲁tide进行体重控制的患者进行了12个月的随访,基线不平等进行重叠加权。结果在376名受试者中,135名(35.9%)使用MCLOW,比基线体重减轻更多(-6.07 [95% CI:6.90至-5.24]对-1.66 [95% CI:2.22至-1.1]kg, p值<; 0.001),体重减轻≥5%和≥10%的比例更高(68.15%对23.65%,p <; 0.001和32.59%对7.05%,p值<; 0.001)。结果与处理加权模型的重叠和逆概率一致。通过网络药理学,MCLOW的使用与脂质代谢和免疫相关途径有关,而利拉鲁肽与胰岛素分泌途径有关。结论中药复方MCLOW具有良好的减肥效果,其作用机制与西药不同,但与西药互补。
{"title":"Comparative effectiveness of Chinese herbal medicine versus liraglutide for weight loss in adults with obesity: A 12-month real-world target trial emulation study","authors":"Yu-Ning Liao ,&nbsp;Tsung-Hsien Yang ,&nbsp;Yi-Chin Lu ,&nbsp;Liang-Wei Tseng ,&nbsp;Ching-Wei Yang ,&nbsp;Yu-Tung Huang ,&nbsp;Hsing-Yu Chen","doi":"10.1016/j.imr.2026.101291","DOIUrl":"10.1016/j.imr.2026.101291","url":null,"abstract":"<div><h3>Background</h3><div>Chinese herbal medicine (CHM) is commonly used for weight control in Taiwan. This study aimed to compare the effectiveness and mechanisms of a fixed combination of CHM with liraglutide using a target trial emulation real-world study.</div></div><div><h3>Methods</h3><div>From January 1, 2013, to December 31, 2018, subjects from the multi-institutional Chang Gung Research Database (CGRD) with a BMI ≥ 25 kg/m² received a fixed combination of Ma-Xing-Gan-Shi-Tang and <em>Coptis chinensis</em> Franch, namely Ma-Xing-Gan-Shi-Tang and Coptis chinensis Franch LOwering Weight formula (MCLOW), were compared with those using liraglutide for weight control for a 12-month follow-up course with overlap weighting for baseline inequality.</div></div><div><h3>Results</h3><div>Among 376 subjects, 135 (35.9%) used MCLOW, who lost more weight from baseline (-6.07 [95% CI:6.90 to -5.24] vs. -1.66 [95% CI:2.22 to -1.1] kg; p-value &lt; 0.001), and had a higher proportion achieved weight reductions of ≥ 5% and ≥ 10% (68.15% vs. 23.65%, <em>p</em> &lt; 0.001 and 32.59% vs. 7.05%, p-value &lt; 0.001, respectively). The results were consistent with overlap and inverse probability of treatment weighting models. By using network pharmacology, use of MCLOW was associated with lipid metabolism and immune-related pathways, while liraglutide was linked to insulin-secretion pathways.</div></div><div><h3>Conclusion</h3><div>The CHM formula MCLOW appears to have promising effects on weight loss, with mechanisms differing from but complementary to those of Western medicines.</div></div>","PeriodicalId":13644,"journal":{"name":"Integrative Medicine Research","volume":"15 3","pages":"Article 101291"},"PeriodicalIF":3.0,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146075248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quantifying the therapeutic index of acupoints using measurements of effective and hazardous depths 用测量有效和危险深度来量化穴位的治疗指数
IF 3 4区 医学 Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2026-09-01 Epub Date: 2026-01-09 DOI: 10.1016/j.imr.2026.101305
Dha-Hyun Choi , Beomku Kang , Heeyoung Moon , Minjae Lee , Da-Eun Yoon , In-Seon Lee , Younbyoung Chae

Background

Acupuncture needles are widely used to treat various medical conditions, but can occasionally lead to serious adverse events. The therapeutic index (TI), originally developed in pharmacology to quantify the safety margin between effective and toxic doses, provides a valuable potential framework for evaluating anatomical safety in acupuncture.

Methods

We applied the TI concept to two commonly used acupoints—GB21 and ST36—by quantifying the TI value, defined as the ratio of the median hazardous depth (HD₅₀) to the median effective depth (ED₅₀), based on ultrasound-guided measurement and de-qi responses. Using ultrasound-guided measurements in 39 participants, we calculated the TI for each point and constructed cumulative distribution functions to visualize the therapeutic window.

Results

GB21 demonstrated a TI of 1.54, indicating a relatively wide safety margin, whereas ST36 had a TI of 1.09, reflecting a narrow and potentially risk-prone margin.

Conclusions

These findings emphasize the impact of anatomical variability and highlight the need for personalized depth control in acupuncture practice. Our study provides preliminary evidence that integrating the TI concept into acupuncture safety assessment may support more individualized, data-driven needling strategies. These findings should be interpreted as exploratory and require confirmation in larger, demographically diverse populations and at additional acupoints before being generalized to routine clinical practice.
针灸针被广泛用于治疗各种疾病,但偶尔会导致严重的不良事件。治疗指数(TI)最初是在药理学中发展起来的,用于量化有效剂量和毒性剂量之间的安全边际,为评估针灸的解剖安全性提供了一个有价值的潜在框架。方法我们将TI概念应用于两个常用的穴位- gb21和st36 -通过量化TI值,定义为基于超声引导测量和deqi响应的中位危险深度(HD₅0)与中位有效深度(ED₅0)的比率。使用超声引导测量39名参与者,我们计算了每个点的TI,并构建了累积分布函数来可视化治疗窗口。结果gb21的TI值为1.54,表明其具有较宽的安全边际,而ST36的TI值为1.09,表明其具有较窄的潜在风险边际。结论这些发现强调了解剖变异的影响,并强调了针灸实践中个性化深度控制的必要性。我们的研究提供了初步证据,表明将TI概念整合到针灸安全性评估中可能支持更个性化的、数据驱动的针刺策略。这些发现应该被解释为探索性的,在推广到常规临床实践之前,需要在更大的、人口统计学上多样化的人群和其他穴位上进行证实。
{"title":"Quantifying the therapeutic index of acupoints using measurements of effective and hazardous depths","authors":"Dha-Hyun Choi ,&nbsp;Beomku Kang ,&nbsp;Heeyoung Moon ,&nbsp;Minjae Lee ,&nbsp;Da-Eun Yoon ,&nbsp;In-Seon Lee ,&nbsp;Younbyoung Chae","doi":"10.1016/j.imr.2026.101305","DOIUrl":"10.1016/j.imr.2026.101305","url":null,"abstract":"<div><h3>Background</h3><div>Acupuncture needles are widely used to treat various medical conditions, but can occasionally lead to serious adverse events. The therapeutic index (TI), originally developed in pharmacology to quantify the safety margin between effective and toxic doses, provides a valuable potential framework for evaluating anatomical safety in acupuncture.</div></div><div><h3>Methods</h3><div>We applied the TI concept to two commonly used acupoints—GB21 and ST36—by quantifying the TI value, defined as the ratio of the median hazardous depth (HD₅₀) to the median effective depth (ED₅₀), based on ultrasound-guided measurement and <em>de-qi</em> responses. Using ultrasound-guided measurements in 39 participants, we calculated the TI for each point and constructed cumulative distribution functions to visualize the therapeutic window.</div></div><div><h3>Results</h3><div>GB21 demonstrated a TI of 1.54, indicating a relatively wide safety margin, whereas ST36 had a TI of 1.09, reflecting a narrow and potentially risk-prone margin.</div></div><div><h3>Conclusions</h3><div>These findings emphasize the impact of anatomical variability and highlight the need for personalized depth control in acupuncture practice. Our study provides preliminary evidence that integrating the TI concept into acupuncture safety assessment may support more individualized, data-driven needling strategies. These findings should be interpreted as exploratory and require confirmation in larger, demographically diverse populations and at additional acupoints before being generalized to routine clinical practice.</div></div>","PeriodicalId":13644,"journal":{"name":"Integrative Medicine Research","volume":"15 3","pages":"Article 101305"},"PeriodicalIF":3.0,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146170584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Demographic and behavioral correlation of red ginseng consumption in Korea 韩国红参消费的人口统计学和行为学相关性
IF 3 4区 医学 Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2026-09-01 Epub Date: 2025-12-31 DOI: 10.1016/j.imr.2025.101287
DeYu Tian , KeunOh Choi , Yong-ung Kim , YoungJoo Lee

Background

As one of the most famous ginseng products, red ginseng has had a huge market and influence in the healthcare market.

Methods

We recruited 3000 adults of all ages and social classes from different parts of Korea to conduct a questionnaire survey for statistical analysis and analyzed the results of the questionnaire survey through logistic regression. The questionnaire included information on the experience of red ginseng intake in a year, whether or not they consumed red ginseng on a regular basis, as well as information on income, age, and family composition that may affect red ginseng intake.

Results

The results showed that men and high-income groups had a higher acceptance of red ginseng; children number of the family has a non-linear effect on the probability of trying red ginseng; and groups who take other dietary supplements were also more willing to take red ginseng.

Conclusions

These results provide valuable information for understanding the demographic and behavioral characteristics of red ginseng consumers and highlight the need to consider integrated health strategies, as well as providing data to inform the development of red ginseng products and the direction of campaigns to promote red ginseng applications.
红参作为最著名的人参产品之一,在保健市场上有着巨大的市场和影响。方法从韩国不同地区招募3000名不同年龄、社会阶层的成年人进行问卷调查,并对问卷调查结果进行logistic回归分析。调查问卷包括一年内摄入红参的经历,是否定期食用红参,以及收入、年龄和家庭构成等可能影响红参摄入量的信息。结果男性和高收入人群对红参的接受程度较高;家庭子女数对尝试红参的概率呈非线性影响;服用其他膳食补充剂的人也更愿意服用红参。结论本研究结果为了解红参消费者的人口学特征和行为特征提供了有价值的信息,强调了综合健康策略的必要性,并为红参产品的开发和推广红参应用的运动方向提供了数据。
{"title":"Demographic and behavioral correlation of red ginseng consumption in Korea","authors":"DeYu Tian ,&nbsp;KeunOh Choi ,&nbsp;Yong-ung Kim ,&nbsp;YoungJoo Lee","doi":"10.1016/j.imr.2025.101287","DOIUrl":"10.1016/j.imr.2025.101287","url":null,"abstract":"<div><h3>Background</h3><div>As one of the most famous ginseng products, red ginseng has had a huge market and influence in the healthcare market.</div></div><div><h3>Methods</h3><div>We recruited 3000 adults of all ages and social classes from different parts of Korea to conduct a questionnaire survey for statistical analysis and analyzed the results of the questionnaire survey through logistic regression. The questionnaire included information on the experience of red ginseng intake in a year, whether or not they consumed red ginseng on a regular basis, as well as information on income, age, and family composition that may affect red ginseng intake.</div></div><div><h3>Results</h3><div>The results showed that men and high-income groups had a higher acceptance of red ginseng; children number of the family has a non-linear effect on the probability of trying red ginseng; and groups who take other dietary supplements were also more willing to take red ginseng.</div></div><div><h3>Conclusions</h3><div>These results provide valuable information for understanding the demographic and behavioral characteristics of red ginseng consumers and highlight the need to consider integrated health strategies, as well as providing data to inform the development of red ginseng products and the direction of campaigns to promote red ginseng applications.</div></div>","PeriodicalId":13644,"journal":{"name":"Integrative Medicine Research","volume":"15 3","pages":"Article 101287"},"PeriodicalIF":3.0,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145986700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Methodological quality of clinical practice guidelines and technical operation norms in acupuncture and moxibustion: Evaluation using AGREE II and STAR 针灸临床实践指南和技术操作规范的方法学质量:使用AGREE II和STAR进行评价
IF 3 4区 医学 Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2026-09-01 Epub Date: 2026-01-25 DOI: 10.1016/j.imr.2026.101307
Pei Yong Loh , Dongsheng Ba , Xue Zhao , Xinru Yuan , Xiaoyan Lyu , Jiani Ma , Hui Zhang , Changqi Li , Xinyang Li , Moran Hei , Zecheng Xu , Huie Ma , Leilin Liu , Yiru Li , Tianyi Zhao , Zelin Chen , Xu Wang , Yaolong Chen , Yang Guo , Yi Guo , Bo Chen

Background

The methodological quality of current acupuncture and moxibustion clinical practice guidelines and technical operation norms remain unclear. Given their potential impact on clinical decision-making and health policy, this study aimed to evaluate their quality using the AGREE II and STAR tools, and to explore the need for a tailored appraisal tool for Traditional Chinese Medicine (TCM) technical operation norms.

Methods

A methodological evaluation was conducted using standardized appraisal instruments. A systematic search across 14 databases identified guidelines and norms related to acupuncture and moxibustion published up to December 31, 2025. Two independent reviewers assessed the included documents using Appraisal of Guidelines for Research and Evaluation II (AGREE II) and Scientific, Transparent, Applicable Rating (STAR) tools.

Results

Seventy-six publications were included: 31 clinical practice guidelines and 45 technical operation norms. AGREE II results showed that 29 guidelines scored >50% in 4 out of 6 domains, while 7 norms met the criterion. STAR evaluation showed an overall score of 64.4% for guidelines versus 15.3% for norms.

Conclusions

This study found that acupuncture and moxibustion clinical practice guidelines generally demonstrate moderate methodological quality, whereas technical operation norms consistently show low scores across multiple domains, indicating substantial room for improvement. These findings also suggest that commonly used appraisal tools, such as AGREE II and STAR, may not fully capture the unique characteristics of TCM technical documents. Future work should develop TCM-specific appraisal tools and improve implementation.
背景现行针灸临床实践指南和技术操作规范的方法学质量尚不明确。鉴于它们对临床决策和卫生政策的潜在影响,本研究旨在利用AGREE II和STAR工具评估它们的质量,并探讨为中医技术操作规范量身定制评估工具的必要性。方法采用标准化评价工具进行方法学评价。通过对14个数据库的系统搜索,确定了截至2025年12月31日出版的与针灸相关的指南和规范。两名独立审稿人使用《研究与评估指南评估II》(AGREE II)和科学、透明、适用评级(STAR)工具对纳入的文件进行了评估。结果共收录文献76篇:临床实践指南31篇,技术操作规范45篇。AGREE II的结果显示,29个指南在6个领域中的4个领域得分为50%,而7个规范符合标准。STAR评估显示,指南的总得分为64.4%,而规范的总得分为15.3%。结论本研究发现,针灸临床实践指南的方法学质量总体上表现为中等水平,而技术操作规范在多个领域的得分一直较低,表明有很大的改进空间。这些发现还表明,常用的评估工具,如AGREE II和STAR,可能无法完全捕捉中医技术文件的独特特征。未来的工作应开发针对中医的评估工具并改进实施。
{"title":"Methodological quality of clinical practice guidelines and technical operation norms in acupuncture and moxibustion: Evaluation using AGREE II and STAR","authors":"Pei Yong Loh ,&nbsp;Dongsheng Ba ,&nbsp;Xue Zhao ,&nbsp;Xinru Yuan ,&nbsp;Xiaoyan Lyu ,&nbsp;Jiani Ma ,&nbsp;Hui Zhang ,&nbsp;Changqi Li ,&nbsp;Xinyang Li ,&nbsp;Moran Hei ,&nbsp;Zecheng Xu ,&nbsp;Huie Ma ,&nbsp;Leilin Liu ,&nbsp;Yiru Li ,&nbsp;Tianyi Zhao ,&nbsp;Zelin Chen ,&nbsp;Xu Wang ,&nbsp;Yaolong Chen ,&nbsp;Yang Guo ,&nbsp;Yi Guo ,&nbsp;Bo Chen","doi":"10.1016/j.imr.2026.101307","DOIUrl":"10.1016/j.imr.2026.101307","url":null,"abstract":"<div><h3>Background</h3><div>The methodological quality of current acupuncture and moxibustion clinical practice guidelines and technical operation norms remain unclear. Given their potential impact on clinical decision-making and health policy, this study aimed to evaluate their quality using the AGREE II and STAR tools, and to explore the need for a tailored appraisal tool for Traditional Chinese Medicine (TCM) technical operation norms.</div></div><div><h3>Methods</h3><div>A methodological evaluation was conducted using standardized appraisal instruments. A systematic search across 14 databases identified guidelines and norms related to acupuncture and moxibustion published up to December 31, 2025. Two independent reviewers assessed the included documents using Appraisal of Guidelines for Research and Evaluation II (AGREE II) and Scientific, Transparent, Applicable Rating (STAR) tools.</div></div><div><h3>Results</h3><div>Seventy-six publications were included: 31 clinical practice guidelines and 45 technical operation norms. AGREE II results showed that 29 guidelines scored &gt;50% in 4 out of 6 domains, while 7 norms met the criterion. STAR evaluation showed an overall score of 64.4% for guidelines versus 15.3% for norms.</div></div><div><h3>Conclusions</h3><div>This study found that acupuncture and moxibustion clinical practice guidelines generally demonstrate moderate methodological quality, whereas technical operation norms consistently show low scores across multiple domains, indicating substantial room for improvement. These findings also suggest that commonly used appraisal tools, such as AGREE II and STAR, may not fully capture the unique characteristics of TCM technical documents. Future work should develop TCM-specific appraisal tools and improve implementation.</div></div>","PeriodicalId":13644,"journal":{"name":"Integrative Medicine Research","volume":"15 3","pages":"Article 101307"},"PeriodicalIF":3.0,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146170583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrating east Asian traditional medicine into National Dementia care: A comparative policy analysis of China, Japan, and South Korea 将东亚传统医学纳入国家痴呆症护理:中国、日本和韩国的比较政策分析
IF 3 4区 医学 Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2026-09-01 Epub Date: 2026-01-05 DOI: 10.1016/j.imr.2026.101290
Chan-Young Kwon , Chen Shen , Tetsuhiro Yoshino , Jihyeon Lee , Yujin Han
{"title":"Integrating east Asian traditional medicine into National Dementia care: A comparative policy analysis of China, Japan, and South Korea","authors":"Chan-Young Kwon ,&nbsp;Chen Shen ,&nbsp;Tetsuhiro Yoshino ,&nbsp;Jihyeon Lee ,&nbsp;Yujin Han","doi":"10.1016/j.imr.2026.101290","DOIUrl":"10.1016/j.imr.2026.101290","url":null,"abstract":"","PeriodicalId":13644,"journal":{"name":"Integrative Medicine Research","volume":"15 3","pages":"Article 101290"},"PeriodicalIF":3.0,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146024984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety of herbal medicine decoction for facial palsy: Coarsened exact matching analysis of the national health insurance database 面瘫中草药汤剂的安全性:国家医保数据库的粗化精确匹配分析
IF 3 4区 医学 Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2026-06-01 Epub Date: 2025-11-26 DOI: 10.1016/j.imr.2025.101279
Yongjoo Kim , Nan-He Yoon , Soobin Jang , Kyeore Bae , Wonkyung Moon , Minjung Park , Sujin Kim

Background

Herbal medicine decoctions (HMD) are potential treatments for Bell’s palsy (BP), but real-world evidence regarding the safety is limited. This study investigated whether HMD use for BP was associated with risk of adverse events using a nationwide claims-based database in South Korea.

Methods

This retrospective cohort study used data from the Korean Health Insurance Review and Assessment database. We applied coarsened exact matching, through which 1627 BP patients who received at least one HMD prescription between November 2020 and February 2022 were matched with 1627 BP patients who did not use HMD. Difference-in-differences logistic regression modeling compared the incidences of safety outcomes between HMD users and non-users.

Results

No significant differences were observed in the risk of hepatotoxicity, renal failure, allergic events, hospitalization, and emergency department visits between HMD users and non-users with BP, assessed at 3, 6, 9 and 11 months after HMD prescription. All effect estimates and corresponding 95 % confidence intervals included the null value.

Conclusions

There was no significant difference in the risk of safety outcomes between HMD users and non-users with BP. Further research is warranted to understand the safety of specific herbal formulas or individual herbs using broader safety measures.
草药煎剂(HMD)是治疗贝尔氏麻痹(BP)的潜在方法,但有关其安全性的实际证据有限。本研究调查了HMD用于治疗BP是否与不良事件风险相关,该研究使用了韩国一个基于索赔的全国性数据库。方法回顾性队列研究使用韩国健康保险审查和评估数据库的数据。我们采用粗化精确匹配,将1627名在2020年11月至2022年2月期间至少服用过一次HMD处方的BP患者与1627名未使用HMD的BP患者进行匹配。差异中差异逻辑回归模型比较了HMD使用者和非使用者之间安全结局的发生率。结果:处方后3、6、9和11个月,HMD使用者和未使用HMD的BP患者在肝毒性、肾衰竭、过敏事件、住院和急诊就诊的风险方面没有观察到显著差异。所有的效应估计值和相应的95%置信区间都包括零值。结论HMD使用者与非使用者BP患者的安全结局风险无显著差异。进一步的研究是必要的,以了解具体的草药配方的安全性或个别草药使用更广泛的安全措施。
{"title":"Safety of herbal medicine decoction for facial palsy: Coarsened exact matching analysis of the national health insurance database","authors":"Yongjoo Kim ,&nbsp;Nan-He Yoon ,&nbsp;Soobin Jang ,&nbsp;Kyeore Bae ,&nbsp;Wonkyung Moon ,&nbsp;Minjung Park ,&nbsp;Sujin Kim","doi":"10.1016/j.imr.2025.101279","DOIUrl":"10.1016/j.imr.2025.101279","url":null,"abstract":"<div><h3>Background</h3><div>Herbal medicine decoctions (HMD) are potential treatments for Bell’s palsy (BP), but real-world evidence regarding the safety is limited. This study investigated whether HMD use for BP was associated with risk of adverse events using a nationwide claims-based database in South Korea.</div></div><div><h3>Methods</h3><div>This retrospective cohort study used data from the Korean Health Insurance Review and Assessment database. We applied coarsened exact matching, through which 1627 BP patients who received at least one HMD prescription between November 2020 and February 2022 were matched with 1627 BP patients who did not use HMD. Difference-in-differences logistic regression modeling compared the incidences of safety outcomes between HMD users and non-users.</div></div><div><h3>Results</h3><div>No significant differences were observed in the risk of hepatotoxicity, renal failure, allergic events, hospitalization, and emergency department visits between HMD users and non-users with BP, assessed at 3, 6, 9 and 11 months after HMD prescription. All effect estimates and corresponding 95 % confidence intervals included the null value.</div></div><div><h3>Conclusions</h3><div>There was no significant difference in the risk of safety outcomes between HMD users and non-users with BP. Further research is warranted to understand the safety of specific herbal formulas or individual herbs using broader safety measures.</div></div>","PeriodicalId":13644,"journal":{"name":"Integrative Medicine Research","volume":"15 2","pages":"Article 101279"},"PeriodicalIF":3.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146074091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prospective registration of guidelines and consensus statements of traditional and integrative medicine: Current status and experience from the PREPARE platform 传统和中西医结合指南和共识声明的前瞻性注册:PREPARE平台的现状和经验
IF 3 4区 医学 Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2026-06-01 Epub Date: 2025-10-03 DOI: 10.1016/j.imr.2025.101260
Xuan Yu , Jie Zhang , Janne Estill , Zhaoxiang Bian , Yaolong Chen

Background

Prospective registration of guidelines enhances transparency and reduces research waste. With the growing number of Traditional and Integrative Medicine (TIM) guidelines, the purpose of this study was to analyze the registrations of TIM guidelines and consensus statements on the Practice guideline REgistration for transPAREncy (PREPARE) platform.

Methods

All TIM guidelines and consensus statements registered on PREPARE by December 31, 2024, were included. Data on registration year, type, category, country, evidence grading, funding, use of systematic reviews, and protocols were extracted and summarized as frequencies and percentages.

Results

As of December 31, 2024, a total of 3434 projects had been registered on PREPARE, of which 587 (17.1%) pertained to traditional and integrative medicine. Among these, 380 (64.7%) were traditional medicine guidelines and consensus statements, and 207 (35.3%) involved integrative medicine. Of the TIM-related guidelines and consensus statements, 401 were standard guidelines and 150 were consensus statements; most (551/587, 93.9%) were registrations for original versions. Nearly half (268/587, 45.7%) addressed both diagnostic and treatment procedures. The majority of registrations (511/587, 87.1%) reported that systematic reviews would inform guidelines and consensus statements. Furthermore, 501 (85.3%) guidelines and consensus statements stated they would grade the strength of evidence and recommendations, with the grading methods specified. Approximately 80% (466/587) explicitly reported their sources of funding, amounting to 632 individual funding sources.

Conclusion

Despite increased use of public platforms for registration, further efforts are needed to improve awareness and practice. The PREPARE working group will collaborate with TIM guideline developers to implement initiatives that advance the rigor, transparency, and usability of TIM guidelines and consensus statements.
指南的前瞻性注册提高了透明度,减少了研究浪费。随着传统与中西医结合(TIM)指南的数量不断增加,本研究的目的是分析TIM指南的注册情况以及实践指南透明度注册(PREPARE)平台上的共识声明。方法纳入截至2024年12月31日在prep上注册的所有TIM指南和共识声明。提取有关注册年份、类型、类别、国家、证据分级、资金、系统评价的使用和方案的数据,并将其总结为频率和百分比。结果截至2024年12月31日,共登记项目3434个,其中中西医结合项目587个,占17.1%。其中,380份(64.7%)为传统医学指南和共识声明,207份(35.3%)涉及中西医结合。在与tim相关的指南和共识声明中,401份是标准指南,150份是共识声明;绝大多数(551/587,93.9%)为原版本注册。近一半(268/587,45.7%)涉及诊断和治疗程序。大多数注册者(511/587,87.1%)报告系统评价将为指南和共识声明提供信息。此外,501条(85.3%)指南和共识声明表示,他们将根据指定的分级方法对证据和建议的强度进行分级。大约80%(466/587)明确报告了其资金来源,共计632个个人资金来源。结论尽管公共注册平台的使用有所增加,但仍需进一步努力提高认识和实践。PREPARE工作组将与TIM指南开发人员合作,实施提高TIM指南和共识声明的严谨性、透明度和可用性的计划。
{"title":"Prospective registration of guidelines and consensus statements of traditional and integrative medicine: Current status and experience from the PREPARE platform","authors":"Xuan Yu ,&nbsp;Jie Zhang ,&nbsp;Janne Estill ,&nbsp;Zhaoxiang Bian ,&nbsp;Yaolong Chen","doi":"10.1016/j.imr.2025.101260","DOIUrl":"10.1016/j.imr.2025.101260","url":null,"abstract":"<div><h3>Background</h3><div>Prospective registration of guidelines enhances transparency and reduces research waste. With the growing number of Traditional and Integrative Medicine (TIM) guidelines, the purpose of this study was to analyze the registrations of TIM guidelines and consensus statements on the Practice guideline REgistration for transPAREncy (PREPARE) platform.</div></div><div><h3>Methods</h3><div>All TIM guidelines and consensus statements registered on PREPARE by December 31, 2024, were included. Data on registration year, type, category, country, evidence grading, funding, use of systematic reviews, and protocols were extracted and summarized as frequencies and percentages.</div></div><div><h3>Results</h3><div>As of December 31, 2024, a total of 3434 projects had been registered on PREPARE, of which 587 (17.1%) pertained to traditional and integrative medicine. Among these, 380 (64.7%) were traditional medicine guidelines and consensus statements, and 207 (35.3%) involved integrative medicine. Of the TIM-related guidelines and consensus statements, 401 were standard guidelines and 150 were consensus statements; most (551/587, 93.9%) were registrations for original versions. Nearly half (268/587, 45.7%) addressed both diagnostic and treatment procedures. The majority of registrations (511/587, 87.1%) reported that systematic reviews would inform guidelines and consensus statements. Furthermore, 501 (85.3%) guidelines and consensus statements stated they would grade the strength of evidence and recommendations, with the grading methods specified. Approximately 80% (466/587) explicitly reported their sources of funding, amounting to 632 individual funding sources.</div></div><div><h3>Conclusion</h3><div>Despite increased use of public platforms for registration, further efforts are needed to improve awareness and practice. The PREPARE working group will collaborate with TIM guideline developers to implement initiatives that advance the rigor, transparency, and usability of TIM guidelines and consensus statements.</div></div>","PeriodicalId":13644,"journal":{"name":"Integrative Medicine Research","volume":"15 2","pages":"Article 101260"},"PeriodicalIF":3.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145690704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Practitioner Experiences of Integrative health CarE [PEICE]: A qualitative descriptive study 综合医疗从业经验[PEICE]:一项定性描述性研究
IF 3 4区 医学 Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2026-06-01 Epub Date: 2025-10-10 DOI: 10.1016/j.imr.2025.101261
Matthew J. Leach , Yasamin Veziari , Simon DuBois , Reine DuBois

Background

Evidence suggests that some models of care may have a positive impact on health worker wellbeing and retention. This study set out to understand health practitioners’ experiences of working within an integrative health care (IHC) setting in Australia, and the impact of such on practitioners’ clinical behaviour and well-being.

Methods

The study employed a qualitative descriptive design and purposive sampling. Health care practitioners of any discipline working in an IHC setting in Australia in a clinical capacity were invited to participate in an online, semi-structured interview. Interview audio-recordings were transcribed verbatim and analysed using deductive thematic analysis.

Results

Twenty-four health practitioners from twelve distinct professions partook in an interview. Four themes emerged from the data, including (i) Transition to practice (e.g. Changed approach to patient care), (ii) Professional interactions (e.g. changing perceptions of, and relationships with other healthcare providers), (iii) Job satisfaction (e.g. rewards and frustrations of working in an IHC setting), and (iv) Impacts on health and wellbeing (e.g. positive and negative health impacts).

Conclusion

The study uncovered new insights into health practitioners’ experiences of working within an IHC setting; including impacts on clinical knowledge, skills, behaviours and relationships, as well as practitioner health, wellbeing and job satisfaction. Given the potential implications of these findings on health workforce supply, quality of care and patient satisfaction, there is a need to build upon this work to determine whether the implementation of IHC models of care in different settings yields meaningful and sustainable clinical, social and economic benefit.
背景:有证据表明,某些护理模式可能对卫生工作者的福利和留任产生积极影响。本研究旨在了解健康从业者在澳大利亚综合医疗保健(IHC)环境中工作的经历,以及这些经历对从业者临床行为和健康的影响。方法采用定性描述设计和目的抽样。在澳大利亚的IHC环境中从事临床工作的任何学科的卫生保健从业人员被邀请参加一个在线的、半结构化的访谈。访谈录音被逐字抄录并使用演绎主题分析进行分析。结果24名来自12个不同行业的卫生从业人员参与了访谈。从数据中产生了四个主题,包括(i)向实践的过渡(例如患者护理方法的改变),(ii)专业互动(例如改变对其他医疗保健提供者的看法和关系),(iii)工作满意度(例如在IHC环境中工作的奖励和挫折),以及(iv)对健康和福祉的影响(例如积极和消极的健康影响)。结论:该研究揭示了卫生从业人员在IHC环境中工作的新见解;包括对临床知识、技能、行为和关系的影响,以及从业者的健康、福祉和工作满意度。鉴于这些发现对卫生人力供应、护理质量和患者满意度的潜在影响,有必要在这项工作的基础上确定在不同环境中实施IHC护理模式是否会产生有意义和可持续的临床、社会和经济效益。
{"title":"Practitioner Experiences of Integrative health CarE [PEICE]: A qualitative descriptive study","authors":"Matthew J. Leach ,&nbsp;Yasamin Veziari ,&nbsp;Simon DuBois ,&nbsp;Reine DuBois","doi":"10.1016/j.imr.2025.101261","DOIUrl":"10.1016/j.imr.2025.101261","url":null,"abstract":"<div><h3>Background</h3><div>Evidence suggests that some models of care may have a positive impact on health worker wellbeing and retention. This study set out to understand health practitioners’ experiences of working within an integrative health care (IHC) setting in Australia, and the impact of such on practitioners’ clinical behaviour and well-being.</div></div><div><h3>Methods</h3><div>The study employed a qualitative descriptive design and purposive sampling. Health care practitioners of any discipline working in an IHC setting in Australia in a clinical capacity were invited to participate in an online, semi-structured interview. Interview audio-recordings were transcribed verbatim and analysed using deductive thematic analysis.</div></div><div><h3>Results</h3><div>Twenty-four health practitioners from twelve distinct professions partook in an interview. Four themes emerged from the data, including (i) Transition to practice (e.g. Changed approach to patient care), (ii) Professional interactions (e.g. changing perceptions of, and relationships with other healthcare providers), (iii) Job satisfaction (e.g. rewards and frustrations of working in an IHC setting), and (iv) Impacts on health and wellbeing (e.g. positive and negative health impacts).</div></div><div><h3>Conclusion</h3><div>The study uncovered new insights into health practitioners’ experiences of working within an IHC setting; including impacts on clinical knowledge, skills, behaviours and relationships, as well as practitioner health, wellbeing and job satisfaction. Given the potential implications of these findings on health workforce supply, quality of care and patient satisfaction, there is a need to build upon this work to determine whether the implementation of IHC models of care in different settings yields meaningful and sustainable clinical, social and economic benefit.</div></div>","PeriodicalId":13644,"journal":{"name":"Integrative Medicine Research","volume":"15 2","pages":"Article 101261"},"PeriodicalIF":3.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145525683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of shared decision-making on patient-reported outcomes in Traditional Chinese Medicine in Shanghai, China: a cross-sectional study using structural equation modeling 共享决策对中国上海中医患者报告结果的影响:一项使用结构方程模型的横断面研究
IF 3 4区 医学 Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2026-06-01 Epub Date: 2025-09-23 DOI: 10.1016/j.imr.2025.101255
Fuming Li , Shimeng Liu , Yue Teng , Liu Liu , Juntao Yan , Yingyao Chen , Yan Wei

Background

Shared decision-making (SDM) is increasingly recognized as a preferred model for cancer care, yet its relationship with patient-reported outcomes remains unclear in the context of Traditional Chinese Medicine (TCM). This study examined the associations of SDM with decision-making satisfaction, treatment decision usefulness, and health-related quality of life (HRQoL) in TCM.

Methods

This multicenter cross-sectional study was conducted among lung cancer patients treated with TCM anti-cancer injections in Shanghai, China. Participants completed questionnaires assessing SDM, decision-making satisfaction, treatment decision usefulness, and HRQoL. Structural equation modeling was conducted to examine the hypothetical model.

Results

A total of 347 participants (46.1% female, 64.8 ± 8.7 years) were included. Using the EQ-5D-5 L index value to represent HRQoL, SDM not only directly positively affected both decision-making satisfaction (β = 0.438, 95%CI: 0.206 – 0.639) and treatment decision usefulness (β = 0.380, 95%CI: 0.172 – 0.577), but indirectly positively affected HRQoL through treatment decision usefulness (β = 0.117, 95%CI: 0.028 – 0.290). A similar pattern was identified using the EQ-VAS score, with significant direct effects on decision-making satisfaction (β = 0.438, 95%CI: 0.206 – 0.639) and treatment decision usefulness (β = 0.380, 95%CI: 0.172 – 0.577), as well as an indirect effect on HRQoL through treatment decision usefulness (β = 0.083, 95%CI: 0.009 – 0.224).

Conclusions

SDM plays a positive role in improving decision-making satisfaction, treatment decision usefulness, and HRQoL among patients receiving TCM. These findings indicate its intrinsic value in patient–provider interactions and its associated benefits, potentially fostering the practice of SDM in TCM.
共同决策(SDM)越来越被认为是癌症治疗的首选模式,但在中医(TCM)的背景下,其与患者报告的结果的关系尚不清楚。本研究考察了SDM与中医决策满意度、治疗决策有用性和健康相关生活质量(HRQoL)的关系。方法采用多中心横断面研究方法,对上海地区接受中药抗癌注射剂治疗的肺癌患者进行研究。参与者完成问卷评估SDM、决策满意度、治疗决策有用性和HRQoL。采用结构方程建模对假设模型进行检验。结果共纳入347例患者,其中女性46.1%,年龄64.8±8.7岁。以eq - 5d - 5l指数值代表HRQoL, SDM不仅直接正向影响决策满意度(β = 0.438, 95%CI: 0.206 ~ 0.639)和治疗决策有用性(β = 0.380, 95%CI: 0.172 ~ 0.577),而且通过治疗决策有用性间接正向影响HRQoL (β = 0.117, 95%CI: 0.028 ~ 0.290)。EQ-VAS评分也发现了类似的模式,对决策满意度(β = 0.438, 95%CI: 0.206 - 0.639)和治疗决策有用性(β = 0.380, 95%CI: 0.172 - 0.577)有显著的直接影响,通过治疗决策有用性对HRQoL有间接影响(β = 0.083, 95%CI: 0.009 - 0.224)。结论ssdm对提高中医患者决策满意度、治疗决策有用性和HRQoL具有积极作用。这些发现表明,它在医患互动中的内在价值及其相关益处,可能促进中医中SDM的实践。
{"title":"The impact of shared decision-making on patient-reported outcomes in Traditional Chinese Medicine in Shanghai, China: a cross-sectional study using structural equation modeling","authors":"Fuming Li ,&nbsp;Shimeng Liu ,&nbsp;Yue Teng ,&nbsp;Liu Liu ,&nbsp;Juntao Yan ,&nbsp;Yingyao Chen ,&nbsp;Yan Wei","doi":"10.1016/j.imr.2025.101255","DOIUrl":"10.1016/j.imr.2025.101255","url":null,"abstract":"<div><h3>Background</h3><div>Shared decision-making (SDM) is increasingly recognized as a preferred model for cancer care, yet its relationship with patient-reported outcomes remains unclear in the context of Traditional Chinese Medicine (TCM). This study examined the associations of SDM with decision-making satisfaction, treatment decision usefulness, and health-related quality of life (HRQoL) in TCM.</div></div><div><h3>Methods</h3><div>This multicenter cross-sectional study was conducted among lung cancer patients treated with TCM anti-cancer injections in Shanghai, China. Participants completed questionnaires assessing SDM, decision-making satisfaction, treatment decision usefulness, and HRQoL. Structural equation modeling was conducted to examine the hypothetical model.</div></div><div><h3>Results</h3><div>A total of 347 participants (46.1% female, 64.8 ± 8.7 years) were included. Using the EQ-5D-5 L index value to represent HRQoL, SDM not only directly positively affected both decision-making satisfaction (<em>β</em> = 0.438, 95%CI: 0.206 – 0.639) and treatment decision usefulness (<em>β</em> = 0.380, 95%CI: 0.172 – 0.577), but indirectly positively affected HRQoL through treatment decision usefulness (<em>β</em> = 0.117, 95%CI: 0.028 – 0.290). A similar pattern was identified using the EQ-VAS score, with significant direct effects on decision-making satisfaction (<em>β</em> = 0.438, 95%CI: 0.206 – 0.639) and treatment decision usefulness (<em>β</em> = 0.380, 95%CI: 0.172 – 0.577), as well as an indirect effect on HRQoL through treatment decision usefulness (<em>β</em> = 0.083, 95%CI: 0.009 – 0.224).</div></div><div><h3>Conclusions</h3><div>SDM plays a positive role in improving decision-making satisfaction, treatment decision usefulness, and HRQoL among patients receiving TCM. These findings indicate its intrinsic value in patient–provider interactions and its associated benefits, potentially fostering the practice of SDM in TCM.</div></div>","PeriodicalId":13644,"journal":{"name":"Integrative Medicine Research","volume":"15 2","pages":"Article 101255"},"PeriodicalIF":3.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145270031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Integrative Medicine Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1